Every function in a cell is associated with a particular protein or group of proteins, typically in a well-defined ...
Strategic Implications: Analytical findings reported today underscore ABP-450’s potential to become the first full label therapeutic biosimilar to BOTOX® in the U.S., positioning AEON to address a >$3 ...
Evo’s success wasn’t limited to proteins. When they tested a different toxin that had an RNA-based inhibitor, the system ...
Scientists at St. Jude Children's Research Hospital have created a database that provides updated predicted structures on a ...
Researchers have created an artificial intelligence model that can identify which mutations in human proteins are most likely ...
A new AI model called popEVE can predict how likely each variant in a patient’s genome is to cause disease. The team is ...
This valuable work provides new insights into the role of lysine acetylation of alpha-synuclein, the protein involved in Parkinson's Disease. The evidence is mostly solid, but the claims around the ...
Google's tool for predicting how proteins “fold” turns 5 this year. How is it fitting into biological research—and where is ...
FDA Type 2a meeting scheduled for November 19, 2025, to review AEON’s analytical development plan and initial data –– Positive biosimilarity ...
A team of researchers at the Broad Institute, led by gene-editing pioneer David Liu, has developed a new genome-editing ...
Scientists are turning venom, radioisotopes, engineered proteins, and AI into powerful new tools against cancer. From ...
With the rapid advancements in computer technology and bioinformatics, the prediction of protein-ligand binding sites has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback